I have also heard of the partnership with Pfizer. Of course that's a big deal. but do you know what kind of partnership it is? What are they planning?
They are piloting a study together in Germany, involving patients in intensive care units, undergoing treatment involving antibiotics.
Thanks for the answer. that sounds very interesting. So they are not limited to the platform for data exchange with the doctor, they also conduct clinical trials. I think that's something I've never seen in any Medical Blockchain project.
It is always a good thing when a project like Aimedis has several main pillars. They have their platform, partnerships and now a study with a global pharma company. Aimedis is in a good position to create a real big thing.
A cooperative study with Pfizer - wow, this is something. Pretty good sign of serious attitudes to medicine science. I hope there will be something productive from this study. Anyway, Aimedis is definitely going to deliver us something big in future.
Pfizer is big name and its there since very long time. This partnership will definitely very helpful for Aimedis. I hope they find more of such partners.
Pfizer is multi-Billion dollar company, so this partnership between Aimedis and Pfizer is not small thing, It's really good deal for Aimedis.
If anything it’s a really good indicator of the direction the company wants to go over the next few years this is a good way to set themselves apart from the various projects that don’t go anywhere
This is a very good news. Just like you have said, it is an indication of their plans of greater things to come. With a connection like this, having big guys around you, you can also get motivated to aim for big heights.
This should be a big development, i love partnerships also although i do not know pfizer but from what i have heard the partnership is really a big plus.
If you are interested, you can do Google for Pfizer. Pfizer is pharma company, manufacturing medicine. Revenue is in billions of dollars.
by the way well done team, I'd like to see/read more of this